SC 13G/A 1 greenway13gam1dec13.htm AMENDMENT NO. 1 greenway13gam1dec13.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
SCHEDULE 13G
 
Under the Securities Exchange Act of 1934
(Amendment No. 1 )*
 
 
GREENWAY MEDICAL TECHNOLOGIES, INC.
(Name of Issuer)
 
Common Stock, par value $0.0001 per share
(Title of Class of Securities)
 
39679B 10 3
(CUSIP Number)
 
December 31, 2013
(Date of Event Which Requires Filing of this Statement)
 
 
 
Check the appropriate box to designate the rule pursuant to which this Schedule 13G is filed:
 
[   ]  Rule 13d-1(b)
[   ]  Rule 13d-1(c)
[X]  Rule 13d-1(d)
 
 
 
*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
 
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
 
 
 

 
 
 

 
 
CUSIP No. 39679B 10 3
 
1
 
NAMES OF REPORTING PERSONS:    Investor AB
 
 
2
 
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
 
(a)  [   ]
 
(b)  [   ]
 
 
 
3
 
SEC USE ONLY
 
 
4
 
CITIZENSHIP OR PLACE OF ORGANIZATION
    Sweden
 
 
NUMBER OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON WITH:
 
5
 
SOLE VOTING POWER:   0*
 
 
6
 
SHARED VOTING POWER:   0*
 
 
7
 
SOLE DISPOSITIVE POWER:   0*
 
 
8
 
SHARED DISPOSITIVE POWER:   0*
 
 
9
 
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
    0*
 
 
10
 
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS)    [   ]
 
 
11
 
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
    0.0%*
 
 
12
 
TYPE OF REPORTING PERSON
    HC
 
 
 
*See Item 4 of this Schedule 13G, as amended.  
 
 
 

 
-2-
 
 
 
 
 
Item 1(a).    Name of Issuer:   Greenway Medical Technologies, Inc.
 
Item 1(b).    Address of Issuer's Principal Executive Offices:
          100 Greenway Boulevard
          Carrollton, GA  30117
 
Item 2(a).    Name of Person Filing:    Investor AB
 
Item 2(b).    Address of Principal Business Office or if none, Residence:
 
          The address of the principal business office of the Reporting Person is Arsenalsgatan 8C, S-103, 32 Stockholm, Sweden.
 
Item 2(c).    Citizenship:
 
          The Reporting Person is a limited liability company incorporated under the laws of Sweden.
 
 
Item 2(d).    Title of Class of Securities:
 
          Common Stock, par value $0.0001 per share
 
 
Item 2(e).    CUSIP Number:   39679B 10 3
 
 
Item 3.    Not Applicable
 
 
Item 4.    Ownership:
 
          (a)
Amount beneficially owned:   0*
 
          (b)
Percent of class:   0.0%*
 
          (c)
Number of shares as to which such person has:
 
i.    
Sole power to vote or to direct the vote:   0*
 
ii.    
Shared power to vote or to direct the vote:   0*
 
iii.    
Sole power to dispose or to direct the disposition:   0*
 
iv.    
Shared power to dispose or to direct the disposition:   0*
 
*Based upon the information set forth in the Quarterly Report on Form 10-Q, filed on November 12, 2013, of Greenway Medical Technologies, Inc., a corporation organized under the laws of Delaware (the “Company”), there were 1,000 shares of common stock, par value $0.0001 per share (the “Common Shares”), of the Company issued and outstanding as of November 11, 2013.  As of December 31, 2013, Investor Growth Capital Limited, a Cayman Islands company, and Investor Group, L.P., a Guernsey limited partnership (collectively, the “Funds”), no longer held any Common Stock of the Company.  Investor AB, a limited liability company incorporated under the laws of Sweden (the “Reporting Person”), through one or more intermediate entities, (i) wholly owns Investor Growth Capital Limited and (ii) is the ultimate general partner of Investor Group, L.P.  As a result of the foregoing, the Reporting Person possesses the sole power to vote and the sole power to direct the disposition of all securities of the Company held by the Funds.
 
 
 
 
-3-
 
 
 
 
Item 5.    Ownership of Five Percent or Less of a Class:
 
          If this statemetn is being filed to report the fact that as of the date hereof the reporting person has ceased to be the owner of more than five percent of the class of securities, check the following:  [X]
 
Item 6.    Ownership of More than Five Percent on Behalf of Another Person:
 
          Not applicable.
 
Item 7.    Identification and Classification of Subsidiary Which Acquired the Securities:
 
          Not applicable.
 
Item 8.    Identification and Classification of Members of the Group:
 
          Not applicable.
 
Item 9.    Notice of Dissolution of Group:
 
          Not applicable.
 
Item 10.     Certifications
 
          Not applicable.
 
 
 
 
 
 
-4-
 
 
 
 
 
 
SIGNATURE
 
After reasonable inquiry and to the best of my knowledge and belief, the undersigned certifies that the information set forth in this statement is true, complete and correct.
 
 
 
   
   
 
Dated: February 14, 2014
   
   
 
INVESTOR AB
   
   
 
By: /s/ Michael V. Oporto                 
    Name: Michael V. Oporto
    Title: Authorized Signatory
   
   
 
By: /s/ Stephen M. Campe                 
    Name: Stephen M. Campe
    Title: Authorized Signatory
 
 
 
 
 
Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (See 18 U.S.C. 1001)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
-5-